Oppenheimer Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$693K Buy
2,871
+54
+2% +$13K 0.01% 818
2025
Q1
$686K Buy
2,817
+103
+4% +$25.1K 0.01% 794
2024
Q4
$892K Buy
2,714
+45
+2% +$14.8K 0.01% 750
2024
Q3
$893K Sell
2,669
-50
-2% -$16.7K 0.01% 747
2024
Q2
$743K Buy
2,719
+446
+20% +$122K 0.01% 773
2024
Q1
$786K Sell
2,273
-363
-14% -$126K 0.01% 741
2023
Q4
$851K Sell
2,636
-661
-20% -$213K 0.01% 749
2023
Q3
$1.18M Hold
3,297
0.02% 646
2023
Q2
$1.25M Buy
3,297
+673
+26% +$255K 0.02% 638
2023
Q1
$1.26M Buy
2,624
+339
+15% +$162K 0.02% 618
2022
Q4
$961K Buy
2,285
+757
+50% +$318K 0.02% 691
2022
Q3
$638K Buy
1,528
+37
+2% +$15.4K 0.01% 776
2022
Q2
$737K Sell
1,491
-23
-2% -$11.4K 0.01% 764
2022
Q1
$853K Sell
1,514
-665
-31% -$375K 0.01% 786
2021
Q4
$1.65M Sell
2,179
-482
-18% -$364K 0.02% 609
2021
Q3
$1.98M Buy
2,661
+39
+1% +$29.1K 0.03% 538
2021
Q2
$1.69M Buy
2,622
+29
+1% +$18.7K 0.02% 588
2021
Q1
$1.48M Buy
2,593
+328
+14% +$187K 0.02% 606
2020
Q4
$1.32M Sell
2,265
-15
-0.7% -$8.74K 0.02% 599
2020
Q3
$1.18M Sell
2,280
-580
-20% -$299K 0.02% 569
2020
Q2
$1.29M Sell
2,860
-146
-5% -$65.9K 0.03% 524
2020
Q1
$1.05M Sell
3,006
-424
-12% -$149K 0.03% 533
2019
Q4
$1.27M Hold
3,430
0.03% 562
2019
Q3
$1.14M Sell
3,430
-223
-6% -$74.2K 0.03% 573
2019
Q2
$1.14M Sell
3,653
-73
-2% -$22.8K 0.03% 580
2019
Q1
$1.14M Buy
3,726
+828
+29% +$253K 0.03% 572
2018
Q4
$673K Sell
2,898
-549
-16% -$127K 0.02% 674
2018
Q3
$1.08M Buy
3,447
+1,801
+109% +$564K 0.02% 597
2018
Q2
$475K Sell
1,646
-48
-3% -$13.9K 0.01% 809
2018
Q1
$424K Sell
1,694
-133
-7% -$33.3K 0.01% 830
2017
Q4
$406K Hold
1,827
0.01% 845
2017
Q3
$406K Sell
1,827
-21
-1% -$4.67K 0.01% 849
2017
Q2
$418K Sell
1,848
-303
-14% -$68.5K 0.01% 833
2017
Q1
$428K Buy
+2,151
New +$428K 0.01% 829